menu
    • menu

    Company profile for Aristea Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aristea TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12770 High Bluff Drive, Suite 380 San Diego, CA 92130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aristeatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aristea-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AristeaTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aristea shutters, ending hopes of a Pfizer buyout
    Aristea shutters, ending hopes of a Pfizer buyout

    11 Feb 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/aristea-shutters-ending-hopes-of-a-pfizer-buyout/

    Kyle LaHucik ENDPTS
    11 Feb 2023
    Share Share
    Aristea Appoints Executive Medical Director and Two Clinical Scientists
    Aristea Appoints Executive Medical Director and Two Clinical Scientists

    02 Nov 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/aristea-therapeutics-strengthens-its-team-with-appointments-of-executive-medical-director-and-two-clinical-scientists-as-clinical-programs-progress/?s=82

    BIOSPACE
    02 Nov 2022
    Share Share
    Aristea Appoints EMD and Scientists as Clinical Programs Progress
    Aristea Appoints EMD and Scientists as Clinical Programs Progress

    02 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aristea-therapeutics-strengthens-its-team-with-appointments-of-executive-medical-director-and-two-clinical-scientists-as-clinical-programs-progress-301665294.html

    PRNEWSWIRE
    02 Nov 2022
    Share Share
    Aristea begins patient dosing in phase 2a trial of RIST4721 in hidradenitis
    Aristea begins patient dosing in phase 2a trial of RIST4721 in hidradenitis

    01 Sep 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=152956&sid=2

    PHARMABIZ
    01 Sep 2022
    Share Share
    Aristea Announces Dosing of First Patient in Phase 2a Trial of RIST4721
    Aristea Announces Dosing of First Patient in Phase 2a Trial of RIST4721

    30 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aristea-therapeutics-announces-dosing-of-first-patient-in-phase-2a-trial-of-rist4721-in-hidradenitis-suppurativa-301613225.html

    PRNEWSWIRE
    30 Aug 2022
    Share Share
    Aristea Therapeutics Strengthens its Board of Directors
    Aristea Therapeutics Strengthens its Board of Directors

    24 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aristea-therapeutics-strengthens-its-board-of-directors-with-the-appointment-of-three-accomplished-biopharma-leaders-from-poseida-therapeutics-novo-holdings-and-pfizer-301611303.html

    PRNEWSWIRE
    24 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search